Drug intelligence / Profile preview

miR-4486 mimic

Development stage
Preclinical
Modality
MicroRNA (miRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous, Intratumoral
01

Overview

miR-4486 mimic is a synthetic, double-stranded RNA molecule designed to replicate the biological activity of the endogenous microRNA hsa-miR-4486. Functioning as a tumor suppressor, miR-4486 is often downregulated in various malignancies, including bladder cancer and gastric cancer. The mimic exerts its therapeutic effect by binding to the 3' untranslated regions (UTRs) of specific oncogenic mRNAs, most notably Janus kinase 1 (JAK1) and Wnt family member 5A (WNT5A). This binding leads to the suppression of the JAK1/STAT3 and Wnt signaling pathways, which in turn inhibits cell proliferation, migration, and epithelial-mesenchymal transition (EMT). Currently, miR-4486 mimics are primarily utilized in preclinical research to explore miRNA-based therapeutic strategies for solid tumors and inflammatory conditions.

Other names
microRNA-4486 mimicmicroRNA4486 mimicmicroRNA 4486 mimichsa-miR-4486 mimichsa-miR4486 mimichsa-miR 4486 mimicmiR-4486-3p mimicmiR4486-3p mimicmiR 4486-3p mimic
02

Targets

ATG7 (Ubiquitin-like modifier-activating enzyme ATG7)MAP2K4 (Mitogen-activated protein kinase kinase 4)

Beyond the preview

Go deeper on miR-4486 mimic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-4486 mimic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call